Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does UBIDECARENONE Cause Wrong technique in product usage process? 13 Reports in FDA Database

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

See the Strategy

According to the FDA Adverse Event Reporting System (FAERS), 13 reports of Wrong technique in product usage process have been filed in association with UBIDECARENONE (CO Q 10). This represents 3.6% of all adverse event reports for UBIDECARENONE.

13
Reports of Wrong technique in product usage process with UBIDECARENONE
3.6%
of all UBIDECARENONE reports
0
Deaths
1
Hospitalizations

How Dangerous Is Wrong technique in product usage process From UBIDECARENONE?

Of the 13 reports, 1 (7.7%) required hospitalization.

Is Wrong technique in product usage process Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for UBIDECARENONE. However, 13 reports have been filed with the FAERS database.

What Other Side Effects Does UBIDECARENONE Cause?

Drug ineffective (130) Headache (125) Pain (125) Malaise (115) Off label use (114) Nausea (113) Therapeutic product effect incomplete (113) Abdominal pain (109) Constipation (109) Pyrexia (109)

What Other Drugs Cause Wrong technique in product usage process?

EVOLOCUMAB (21,664) ALBUTEROL (17,114) ADALIMUMAB (11,766) PEGFILGRASTIM (10,217) ETANERCEPT (9,835) ERENUMAB-AOOE (9,359) SACUBITRIL\VALSARTAN (8,022) LEUPROLIDE (5,062) FENTANYL (2,812) SEMAGLUTIDE (2,538)

Which UBIDECARENONE Alternatives Have Lower Wrong technique in product usage process Risk?

UBIDECARENONE vs UBLITUXIMAB UBIDECARENONE vs UBLITUXIMAB-XIIY UBIDECARENONE vs UBROGEPANT UBIDECARENONE vs ULIPRISTAL UBIDECARENONE vs UMBRALISIB

Related Pages

UBIDECARENONE Full Profile All Wrong technique in product usage process Reports All Drugs Causing Wrong technique in product usage process UBIDECARENONE Demographics